Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Braz. j. pharm. sci ; 50(2): 251-256, Apr-Jun/2014. tab, graf
Artigo em Inglês | LILACS | ID: lil-722188

RESUMO

Flunitrazepam (FNZ) is a sedative benzodiazepine prescribed for the short-term treatment of insomnia. However, there are concerns regarding possible carcinogenic or genotoxic effects of this medicine. Thus, the aim of this study was to evaluate the cytotoxic, clastogenic and aneugenic effects of FNZ in hepatoma cells from Rattus norvegicus (HTC) in vitro and in bone marrow cells of Wistar rats in vivo. These effects were examined in vitro following treatment with 0.2, 1.0, 5.0 or 10 μg/mL FNZ using a micronucleus test with a cytokinesis block or in vivo using a chromosomal aberration test following treatment with 7, 15 or 30 μg/mL/kg body weight. The results showed that the benzodiazepine concentrations tested were not cytotoxic, aneugenic or clastogenic. However, considering the adverse effects of using this benzodiazepine, more studies are required.


Flunitrazepam (FNZ) é um sedativo benzodiazepínico prescrito para o tratamento da insônia em curto prazo. Entretanto, existe a preocupação com relação aos possíveis efeitos carcinogênicos ou genotóxicos causados por este fármaco. Então, o objetivo deste estudo foi avaliar os efeitos citotóxicos, clastogênicos e aneugênicos do FNZ em células de hepatoma de Rattus norvegicus (HTC) in vitro e em células de medula óssea de ratos Wistar in vivo. Foram testadas as concentrações de 0,2, 1,0 e 10 μg/mL de FNZ pelo teste do micronúcleo com bloqueio de citocinese in vitro e 7, 15 e 30 μg/mL/kg de peso corpóreo para o teste de aberração cromossômica in vivo. Os resultados mostraram que as concentrações do benzodiazepínico testadas não foram citotóxicas, aneugênicas ou clastogênicas. Entretanto, considerando os efeitos adversos do uso deste benzodiazepínico, mais estudos são necessários.


Assuntos
Ratos , Técnicas In Vitro/instrumentação , Citotoxinas/classificação , Flunitrazepam/análise , Transtornos Cromossômicos , Aneugênicos , Mutagênicos
2.
Parasitology ; 134(Pt 7): 1003-12, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17316476

RESUMO

As we have recently shown that GABA should be considered a putative neurotransmitter in Schistosoma mansoni, the present work aimed to search for GABAA receptors in adult worms using [3H]-flunitrazepam to label the allosteric benzodiazepine binding site which is classically present on GABAA receptor complexes. We detected a large population (Bmax=8.25+/-1.1 pmol x mg protein(-1)) of high affinity (Kd=33.6+/-1.5 nM) binding sites for flunitrazepam. These sites harboured a singular pharmacological modulation that does not fit well with a mammalian central benzodiazepine receptor, mainly due to a very high affinity for Ro5-4864 and a very low affinity for clonazepam. We also detected a second population of benzodiazepine binding sites labelled with high affinity (IC50=85 nM) by [3H]-PK11195, a selective ligand of the mammalian peripheral benzodiazepine receptor. In conclusion, this work describes the pharmacological properties of a large population of central-like benzodiazepine receptors supporting their study as putative new targets for the development of anti-parasitic agents. We also describe, for the first time, the presence of peripheral benzodiazepine receptors in this parasite.


Assuntos
Benzodiazepinas/metabolismo , Receptores de GABA-A/metabolismo , Schistosoma mansoni/metabolismo , Animais , Benzodiazepinonas/metabolismo , Sítios de Ligação , Clonazepam/metabolismo , Clonazepam/farmacologia , Diazepam/metabolismo , Diazepam/farmacologia , Flunitrazepam/análise , Flunitrazepam/metabolismo , Flunitrazepam/farmacologia , Agonistas GABAérgicos/farmacologia , Moduladores GABAérgicos/farmacologia , Concentração Inibidora 50 , Isoquinolinas/metabolismo , Ligantes , Masculino , Piridinas/metabolismo , Piridinas/farmacologia , Ratos , Ratos Wistar , Receptores de GABA-A/classificação , Receptores de GABA-A/efeitos dos fármacos , Schistosoma mansoni/efeitos dos fármacos , Sinaptossomos/metabolismo , Temperatura , Fatores de Tempo , Trítio/análise , Zolpidem
3.
Biochim Biophys Acta ; 1324(1): 76-84, 1997 Feb 21.
Artigo em Inglês | MEDLINE | ID: mdl-9059500

RESUMO

In the present paper we tried to test the hypothesis that nonspecific flunitrazepam-membrane interactions are consistent with drug molecules accommodated between lipid molecules, becoming an integral part of the bilayer. We developed a spectrophotometric method to determine FNTZH+ equilibrium dissociation constant and applied it to the study of the acid-base equilibria of this drug in homogeneous media of different polarity. In these conditions, pK decreased with the decrement in the dielectric constant (D) of the media. These results, analyzed under the light of the theory developed by Fernandez and Fromherz (1977; J. Phys. Chem. 81, 1755-1761) let us infer that flunitrazepam is localized a region with D = 60. This D value is lower that Dwater = 78 and higher than D of hydrocarbon chains zone (D = 2-5) and would correspond to D of the region of polar groups. This result is compatible with the hypothesis.


Assuntos
Flunitrazepam/análise , Bicamadas Lipídicas/química , Equilíbrio Ácido-Base , Concentração de Íons de Hidrogênio , Espectrofotometria Ultravioleta/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA